Possible measles exposure locations in Denver, Boulder after new confirmed case
DENVER (KDVR) — Boulder County has a confirmed case of the measles after a resident returned from a trip to Europe, according to a press release on the Denver Department of Public Health and Environment website on Friday.
One of the best hidden-gem beaches in America is in Colorado: List
The person was a fully vaccinated adult and traveled to several areas in the Denver metro and Boulder County.
Possible exposure locations include:
Location
Date/time
When symptoms may develop
Market Building 1400 16th St. Denver
June 3-6: 8 a.m. to 6:15 p.m.
Through June 27
RTD Flatiron Flyer Denver and Boulder
June 3: 6:45 a.m. to 9:35 a.m. and 4:05 p.m. to 7:15 p.m.
Through June 24
Little Finch Coffee Shop 1490 16th St. Denver
June 4: Noon to 2:15 p.m.
Through June 25
Whole Foods 1701 Wewatta St. Denver
June 4: Noon to 2:30 p.m.
Through June 25
RTD Flatiron Flyer Denver and Boulder
June 5: 6:45 a.m. to 9:35 a.m. and 4:05 p.m. to 7:15 p.m.
Through June 26
Little Finch Coffee Shop 1490 16th St. Denver
June 5: Noon to 2:15 p.m.
Through June 26
RTD Flatiron Flyer Denver and Boulder
June 6: 6:45 a.m. to 9:35 a.m. and 4:05 p.m. to 7:15 p.m.
Through June 27
Rosetta Hall 1109 Walnut St. Boulder
June 6: 7:30 p.m. to 10:45 p.m.
Through June 27
DDPHE said that based on available information, anyone who was in these locations during the dates and times mentioned may have been exposed to measles and should monitor symptoms for 21 days after exposure and consider avoiding public gatherings or high-risk settings.
The department also said that it is especially critical to monitor symptoms for those who have not received the MMR vaccine.
Measles symptoms will typically develop in seven to 21 days after exposure.
Symptoms may manifest in ways, including:
Fever
Cough
Runny nose
Red eyes
Characteristic rash that starts on the face
The Department of Health said that the best way to prevent symptoms and the spread of measles is by getting the MMR vaccination.
For those who do not know if they are vaccinated, visit the Colorado Public Portal website to check the immunization database.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
5 hours ago
- Medscape
Population-Level Weight Loss Seen With Primary Care Protocol
CHICAGO — Encouraging patients to talk with their primary care physicians about weight management led to increased visits for obesity, population-wide weight loss, and increased revenue, researchers at the University of Colorado Anschutz School of Medicine (CU Anschutz) reported here at the American Diabetes Association (ADA) 85th Scientific Sessions. The researchers presented data from a 4-year study of the PATHWEIGH protocol, which was implemented at 56 primary care clinics across Colorado. Ultimately, 274,182 patients were part of the study, which has not yet been published. Although weight loss was low in the intervention group — 0.1 kg at 18 months — the intervention eliminated the typical expected weight gain population-wide. And indeed, that weight gain was about 0.1 kg in those who did not receive the intervention. "Our data is the first to scale an intervention to more than a quarter of a million people and prevent population weight gain," said Leigh Perreault, MD, associate professor of medicine in the division of endocrinology, metabolism and diabetes at CU Anschutz, who presented the data. Using a stepped-wedge cluster randomized trial design, researchers randomized clinics to offer usual care or the intervention. Each clinic eventually moved to using the intervention. Patients who received usual care would have visits during which weight could be discussed but clinicians did not have access to PATHWEIGH tools. Those who received the intervention had weight-specific visits and their doctors had access to the protocol. The Colorado group created PATHWEIGH to help primary care physicians fill the gap in obesity care in the face of growing numbers of overweight and obese Americans. Patients in the usual care or intervention group were alerted to the opportunity to have a weight-prioritized visit with their primary care physician. In the intervention group, patients were asked to complete a weight-management questionnaire before the visit, which the physician could then use as a prompt to talk with the patient during the visit. Researchers also provided clinicians with specialized support tools, education, and most importantly, a weight-specific template embedded in the electronic medical record. The template allowed for diagnosis, documentation of a weight-related discussion (for reimbursement), and orders for referrals, tests, and procedures, which streamlined workflow and made it easier to help patients, said Perreault. Physicians were asked to follow up with patients at least every 4 to 6 weeks. Use of the tools was optional, however. This meant that patients in the intervention group could get usual care with or without PATHWEIGH. At baseline, the mean age of patients was 54 years. About 53% were female, and 78% were non-Hispanic White, 11% Latino, 4% Black, and 2% Asian. Two thirds had commercial insurance and about a third were Medicare enrollees. Mean BMI was 31 kg/m2. At the end of the 4-year study, researchers found only about 25% of patients with a BMI of 25 kg/m2 or more received any discernible care for their weight, said Perreault. Discernible care might include adequate counseling about diet, exercise, and behavioral modification, referral to a dietitian or bariatric surgeon, or prescription of an anti-obesity medication. More people in the intervention group received such care. Those most likely to receive care had a BMI of at least 25 kg/m2, tended to be closer to age 50, were commercially insured, and were Latino or Black. However, said Perreault, an A1c in the prediabetes range, an estimated glomerular filtration rate in the stage 2 chronic kidney disease range, or the presence of a weight-related disease or complication did not prompt clinicians to offer help. Patients who did receive weight-related care during the intervention lost 2.37 kg more than those in the intervention group who received no care. Getting any sort of help with weight management made a difference, even outside the intervention. Those who received usual care offered weight management assistance lost 1.73 kg more than patients in the usual care group who received no care. Perreault said that providers spent no extra time on weight-prioritized visits and that using weight-related International Classification of Diseases 10 codes added more than $15 million to the health system's revenues over the 4-year study. PATHWEIGH outreach also resulted in "more than twice as many" visits for weight management, she said. 'Monumental' But Not 'Hugely Successful' "This is monumental work," said Ildiko Lingvay, MD, MPH, MSCS, a professor of internal medicine at University of Texas Southwestern Medical Center, Dallas, who chaired the session during which the study results were presented. Changing population weight by a pound is "like moving mountains," she said. However, added Lingvay, "It's not that I think this intervention was hugely successful." She's excited to see how the intervention works as it is adopted by others. Robert Kushner, MD, MS, a professor of medicine at Northwestern University Feinberg School of Medicine, Chicago, Illinois, offered the Colorado group "a big congratulations." "This is a really tough nut to crack," said Kushner, who was asked for comment. "There are significant barriers and challenges to treating obesity in primary care," he said. Many approaches basically remove the primary care physician from the equation by diverting patients to online platforms, coaching, or self-help, or weight-loss programs. "Embedding" the primary care physician is "the road less taken, to be honest," said Kushner, which PATHWEIGH successfully does. And it is an "innovative program for a healthcare system, population-level approach to the management of obesity." Looking ahead, the researchers should determine how to increase both clinician and patient engagement, said Kushner. It would also be useful to examine what triggers referrals to other services and to assess clinical outcomes and mediators of weight change, he said. Lastly, researchers should "determine the use and effectiveness of obesity medications. That's extremely important in the day we live," said Kushner. The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases. Perreault has disclosed receiving personal fees for speaking and/or consulting from Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Ascendis, Medscape, WebMD, and UpToDate. Lingvay has reported consulting for AbbVie, Altimmune, Amgen, Alveus, Antag Therapeutics, AstraZeneca, Bayer, Betagenon, Bioio, Biomea, Boehringer Ingelheim, Carmot, Cytoki Pharma, Eli Lilly, Intercept, Janssen/J&J, Juvena, Keros Ther, Novo Nordisk, PharmaVentures, Pfizer, Regeneron, Roche, Sanofi, Shionogi, Source Bio, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, WebMD, and Zealand Pharma. Kushner has reported no conflicts related to PATHWEIGH but disclosed being a board member for Altimmune, Currax, Novo Nordisk, Structure Therapeutics, and Weight Watchers International, and a consultant for Eli Lilly and Regeneron.
Yahoo
10 hours ago
- Yahoo
Whooping cough outbreaks declared in Iqaluit, Pond Inlet
There's an outbreak of whooping cough in Iqaluit and Pond Inlet, Nunavut, according to the territory's chief public health officer. The Department of Health announced the outbreaks in a pair of news releases Saturday. It said anyone can get the respiratory disease — also known as pertussis — but that the most severe cases are in children under the age of one. Though it spreads easily from person to person, the department says it's preventable by getting vaccinated. Symptoms of whooping cough include a low fever, a cough that lasts longer than a week or is followed by an unusual "whoop" sound, vomiting after coughing and coughing that is worse at night. Anyone with these symptoms is told to stay home, avoid contact with others, and to contact their local health centre. The department says whooping cough can spread from the time someone catches it — before they start coughing — until three weeks after their symptoms have started, or until they've been taking treatment for five days. The department says whooping cough can be treated with antibiotics. They're urging people to get vaccinated against the disease, but also to curb the spread with frequent hand washing, coughing into tissues or sleeves, and not sharing food, drinks, utensils or toothbrushes. Outbreaks of whooping cough that began in Kugaruuk and Naujaat in the spring were declared over last month.
Yahoo
13 hours ago
- Yahoo
Measles 'out of control,' experts warn, as Alberta case counts surpass 1,000
Alberta's measles outbreaks have now eclipsed the 1,000-case mark and infectious disease specialists are warning the virus is "impossible to contain," given the current level of transmission. The province reported another 24 cases on Friday, including 14 in the north zone, nine in the south and one in the Edmonton zone. This brings the total confirmed cases since the outbreaks began in March to 1,020. "It is a very grim milestone," said Dr. Karina Top, a pediatric infectious disease physician at the Stollery Children's Hospital in Edmonton, which has been treating children with measles. "I'm very worried we're going to see more hospitalizations and some deaths soon because we know the death rate is about one to two per thousand. So it's likely that we're going to see that and that will be a very tragic day." Measles is highly contagious and can lead to serious complications including pneumonia, brain inflammation — which can trigger seizures, deafness and brain damage — as well as premature delivery. A premature baby who was born with measles died in Ontario recently. And another young child died of measles in that province last year. Doctors warn there are severe long-term consequences as well, including immune system impacts and a degenerative neurological condition that occurs seven to ten years after an initial measles infection. It is rare but nearly always fatal. 'Out of control' Alberta's case count has more than doubled in the last month. On May 20, a total of 486 cases had been confirmed. "This is out of control," said Top. The hardest hit areas are the south, central and north zones, where there are some very low vaccination rates among young children. Case counts have been rising quickly in the north zone, which has now topped 200 cases. The south zone has confirmed 681 cases and the central zone has 105. And health officials are warning the virus is more widespread in those areas than case counts reflect. "Due to the number of people in these areas who may not be immune to measles, it's likely that some cases are going undetected or unreported," the Alberta government's measles web page states. "I think we really need to be doing everything we can to engage with those communities that are affected and community leaders to see how best we can work with them to try to get people vaccinated to help contain this infection," said Top. "And [we need to] get everyone else up to date so that if there are other cases introduced in Edmonton, Calgary or elsewhere in the province, it can be contained more quickly." University of Calgary infectious disease physician Dr. Dan Gregson is also worried about Alberta's surging measles cases. "This transmission is just out of the box. It's impossible to contain at the present time," he said. "The risk, right now, of your child getting measles in Alberta if they're not immunized is pretty high." Gregson is urging parents who have opted not to immunize their children to rethink that decision. "If you had made a decision not to vaccinate because measles was not circulating, that's no longer true. We don't have herd immunity. There's measles circulating in the community. And the best way to prevent your child from having a complication would be to get them vaccinated," he said. The vast majority of Alberta's measles cases are among the unimmunized. The most recent data shows 85 Albertans have been hospitalized due to this year's outbreaks, including 14 who have ended up in intensive care. "Most of these hospitalizations are due to patients having pneumonia — they're short of breath, they have to wear oxygen. Some of them are due to brain inflammation. [It's] not a pleasant thing for the parents or the child to have to go through," said Gregson. In Edmonton, where the Stollery Children's Hospital is treating the sickest patients from northern Alberta, Top said the outbreaks are taking a toll. "It is distressing as a pediatrician to see children that are sick from a disease that is completely vaccine preventable." According to provincial data, as of Friday there was one Albertan in ICU due to measles. No deaths have been reported.
